CytomX Therapeutics Inc (CTMX) — Cash Flow Reinvestment Rate
CytomX Therapeutics Inc (CTMX) has a Cash Flow Reinvestment Rate of 15.69x as of March 2023, reinvesting $146.64 Million (capex $48.00K plus investments $-146.59 Million) from operating cash flow of $9.35 Million. See CTMX free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CytomX Therapeutics Inc Cash Flow Reinvestment Rate (2014–2020)
Historical reinvestment intensity for CytomX Therapeutics Inc across 3 annual periods. For the full cash flow conversion analysis, see CytomX Therapeutics Inc operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for CytomX Therapeutics Inc (2014–2020)
Year-by-year capital reinvestment analysis for CytomX Therapeutics Inc. See CTMX financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 3.56x | $18.72 Million | $5.26 Million | $2.31 Million | ▲ +393.7% |
| 2017 | 0.72x | $122.83 Million | $170.37 Million | $1.56 Million | ▼ -82.3% |
| 2014 | 4.08x | $129.81 Million | $31.80 Million | $1.66 Million | — |